FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

I Marshall

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Phenomena

Muscle Contraction

Physiology

Muscle Relaxation

Co-author Network

Publications

TOP 3
FM Wisskirchen; I Marshall
CGRP(2) receptor in the internal anal sphincter of the rat: implications for CGRP receptor classification.
MB Hussain; I Marshall
Alpha(1)-adrenoceptor subtypes mediating contractions of the rat mesenteric artery.
FM Wisskirchen; PM Doyle; S L Gough; CJ Harris; I Marshall
Bioactive beta-bend structures for the antagonist halpha CGRP(8 - 37) at the CGRP(1) receptor of the rat pulmonary artery.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of I Marshall (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: FM Wisskirchen; I Marshall
CGRP(2) receptor in the internal anal sphincter of the rat: implications for CGRP receptor classification.
British journal of pharmacology 2000;130(2):464-70.
2000: MB Hussain; I Marshall
Alpha(1)-adrenoceptor subtypes mediating contractions of the rat mesenteric artery.
European journal of pharmacology 2000;395(1):69-76.
2000: FM Wisskirchen; PM Doyle; S L Gough; CJ Harris; I Marshall
Bioactive beta-bend structures for the antagonist halpha CGRP(8 - 37) at the CGRP(1) receptor of the rat pulmonary artery.
British journal of pharmacology 2000;129(5):1049-55.
1999: FM Wisskirchen; D W Gray; I Marshall
Receptors mediating CGRP-induced relaxation in the rat isolated thoracic aorta and porcine isolated coronary artery differentiated by h(alpha) CGRP(8-37).
British journal of pharmacology 1999;128(2):283-92.
1999: FM Wisskirchen; PM Doyle; S L Gough; CJ Harris; I Marshall
Conformational restraints revealing bioactive beta-bend structures for halpha CGRP8-37 at the CGRP2 receptor of the rat prostatic vas deferens.
British journal of pharmacology 1999;126(5):1163-70.
1999: I Marshall; Richard P Burt; Christopher Chapple
Signal transduction pathways associated with alpha1-adrenoceptor subtypes in cells and tissues including human prostate.
European urology 1999;36 Suppl 1():42-7; discussion 65.
1998: FM Wisskirchen; Richard P Burt; I Marshall
Pharmacological characterization of CGRP receptors mediating relaxation of the rat pulmonary artery and inhibition of twitch responses of the rat vas deferens.
British journal of pharmacology 1998;123(8):1673-83.
1998: Richard P Burt; Christopher Chapple; I Marshall
Alpha1A-adrenoceptor mediated contraction of rat prostatic vas deferens and the involvement of ryanodine stores and Ca2+ influx stimulated by diacylglycerol and PKC.
British journal of pharmacology 1998;123(2):317-25.
1997: MB Hussain; I Marshall
Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
British journal of pharmacology 1997;122(5):849-58.
1997: S Sooch; I Marshall
Atypical beta-adrenoceptors in the rat vasculature.
Annals of the New York Academy of Sciences 1997;812():211-2.
1997: FM Wisskirchen; I Marshall
The calcitonin gene-related peptide (CGRP) receptor in rat smooth muscles.
Annals of the New York Academy of Sciences 1997;812():205-6.
1996: I Marshall; Richard P Burt; G M Green; M B Hussain; Christopher Chapple
Different subtypes of alpha 1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053.
British journal of pharmacology 1996;119(2):407-15.
1996: Richard P Burt; Christopher Chapple; I Marshall
The role of diacylglycerol and activation of protein kinase C in alpha 1A-adrenoceptor-mediated contraction to noradrenaline of rat isolated epididymal vas deferens.
British journal of pharmacology 1996;117(1):224-30.
1995: Richard P Burt; Christopher Chapple; I Marshall
The role of capacitative Ca2+ influx in the alpha 1B-adrenoceptor-mediated contraction to phenylephrine of the rat spleen.
British journal of pharmacology 1995;116(4):2327-33.
1995: I Marshall; Richard P Burt; Christopher Chapple
Noradrenaline contractions of human prostate mediated by alpha 1A-(alpha 1c-) adrenoceptor subtype.
British journal of pharmacology 1995;115(5):781-6.
1995: Richard P Burt; Christopher Chapple; I Marshall
Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen.
British journal of pharmacology 1995;115(3):467-75.
1994: Christopher Chapple; Richard P Burt; P O Andersson; P Greengrass; M Wyllie; I Marshall
Alpha 1-adrenoceptor subtypes in the human prostate.
British journal of urology 1994;74(5):585-9.
1992: D W Gray; I Marshall
Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide.
British journal of pharmacology 1992;107(3):691-6.
1992: D W Gray; I Marshall
Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta.
British journal of pharmacology 1992;107(3):684-90.
1992: D W Gray; I Marshall
A pharmacological profile of the endothelium-derived relaxant factor released by calcitonin gene-related peptide in rat aorta.
Annals of the New York Academy of Sciences 1992;657():517-8.
1992: I Marshall
Mechanism of vascular relaxation by the calcitonin gene-related peptide.
Annals of the New York Academy of Sciences 1992;657():204-15.
1992: D W Gray; I Marshall
Nitric oxide synthesis inhibitors attenuate calcitonin gene-related peptide endothelium-dependent vasorelaxation in rat aorta.
European journal of pharmacology 1992;212(1):37-42.
1988: I Marshall; S J Al-Kazwini; J J Holman; R K Craig
Human alpha-calcitonin gene-related peptide (CGRP) is a potent vasodilator in human mesenteric vasculature.
British journal of clinical pharmacology 1988;26(6):691-5.
1986: S J Al-Kazwini; R K Craig; I Marshall
Postjunctional inhibition of contractor responses in the mouse vas deferens by rat and human calcitonin gene-related peptides (CGRP).
British journal of pharmacology 1986;88(1):173-80.
1986: I Marshall; S J Al-Kazwini; J J Holman; R K Craig
Human and rat alpha-CGRP but not calcitonin cause mesenteric vasodilatation in rats.
European journal of pharmacology 1986;123(2):217-22.
1986: I Marshall; S J Al-Kazwini; P M Roberts; N B Shepperson; M Adams; R K Craig
Cardiovascular effects of human and rat CGRP compared in the rat and other species.
European journal of pharmacology 1986;123(2):207-16.
1986: J J Holman; R K Craig; I Marshall
Human alpha- and beta-CGRP and rat alpha-CGRP are coronary vasodilators in the rat.
Peptides 1986;7(2):231-5.
1986: R K Craig; J H Riley; M R Edbrooke; P M Broad; S M Foord; S J Al-Kazwini; J J Holman; I Marshall
Expression and function of the human calcitonin/alpha-CGRP gene in health and disease.
Biochemical Society symposium 1986;52():91-105.